论文部分内容阅读
目的探讨甘精胰岛素联合格列美脲治疗2型糖尿病的临床疗效。方法选取本科2012年8月~2013年5月收治50例2型糖尿病患者的临床资料进行研究。结果 50例患者使用甘精胰岛素联合格列美脲治疗后,空腹血糖水平、餐后2 h血糖及糖化血红蛋白水平明显低于治疗前水平,差异具有统计学意义(P<0.05),不良反应发生率为6%。结论甘精胰岛素联合格列美脲治疗2型糖尿病疗效稳定,不良反应小,值得推广使用。
Objective To investigate the clinical efficacy of glargine and glimepiride in the treatment of type 2 diabetes. Methods From August 2012 to May 2013, 50 cases of type 2 diabetes mellitus were enrolled in this study. Results After 50 patients were treated with glargine and glimepiride, the fasting blood glucose levels, 2 h postprandial blood glucose and glycosylated hemoglobin levels were significantly lower than those before treatment, the difference was statistically significant (P <0.05), adverse reactions The rate is 6%. Conclusion Glargine and glimepiride combined with glimepiride are effective in treating type 2 diabetes mellitus with less adverse reactions and are worth promoting.